4588.T
Price:
$923
Market Cap:
$22.93B
Oncolys BioPharma Inc. engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States. Its product pipeline includes Telomelysin (OBP-301), an oncolytic adenovirus that is in phase II clinical trial for the treatment of gastric cancer/gastroesophageal junction, head and neck, and esophageal cancers; and in phase I clinical trial for the treatment of hepatocellular carcinoma. The company's product pipeline also includes OBP-702, a telomerase-specific oncolytic adenovirus, which is in pre-clinical trial for the treatment of solid tumors; OBP-2011, which is in pr...[Read more]
Industry
Biotechnology
IPO Date
2013-12-06
Stock Exchange
JPX
Ticker
4588.T
According to Oncolys BioPharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.78. This represents a change of -31.85% compared to the average of 9.95 of the last 4 quarters.
The mean historical Current Ratio of Oncolys BioPharma Inc. over the last ten years is 10.81. The current 6.78 Current Ratio has changed 6.17% with respect to the historical average. Over the past ten years (40 quarters), 4588.T's Current Ratio was at its highest in in the September 2015 quarter at 26.55. The Current Ratio was at its lowest in in the September 2022 quarter at 4.29.
Average
10.81
Median
11.02
Minimum
5.17
Maximum
20.76
Discovering the peaks and valleys of Oncolys BioPharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 137.58%
Maximum Annual Current Ratio = 20.76
Minimum Annual Increase = -40.76%
Minimum Annual Current Ratio = 5.17
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 12.28 | 137.58% |
| 2023 | 5.17 | -36.29% |
| 2022 | 8.11 | -16.88% |
| 2021 | 9.76 | 59.17% |
| 2020 | 6.13 | -16.08% |
| 2019 | 7.31 | -40.76% |
| 2018 | 12.33 | -4.04% |
| 2017 | 12.85 | -4.15% |
| 2016 | 13.41 | -35.41% |
| 2015 | 20.76 | 11.72% |
The current Current Ratio of Oncolys BioPharma Inc. (4588.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.52
5-year avg
8.29
10-year avg
10.81
Oncolys BioPharma Inc.’s Current Ratio is less than StemRIM (83.35), less than CanBas Co., Ltd. (27.89), less than Japan Tissue Engineering Co., Ltd. (6.85), greater than Astena Holdings Co., Ltd. (1.39), less than CellSeed Inc. (7.13), greater than Fuso Pharmaceutical Industries,Ltd. (1.09), less than ReproCELL Incorporated (9.93), greater than RaQualia Pharma Inc. (4.80), less than MediciNova, Inc. (13.26), greater than Ohki Healthcare Holdings Co.,Ltd. (1.14),
| Company | Current Ratio | Market cap |
|---|---|---|
| 83.35 | $15.78B | |
| 27.89 | $15.57B | |
| 6.85 | $20.39B | |
| 1.39 | $18.41B | |
| 7.13 | $9.36B | |
| 1.09 | $18.29B | |
| 9.93 | $14.87B | |
| 4.80 | $27.61B | |
| 13.26 | $11.53B | |
| 1.14 | $19.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolys BioPharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncolys BioPharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Oncolys BioPharma Inc.'s Current Ratio?
How is the Current Ratio calculated for Oncolys BioPharma Inc. (4588.T)?
What is the highest Current Ratio for Oncolys BioPharma Inc. (4588.T)?
What is the 3-year average Current Ratio for Oncolys BioPharma Inc. (4588.T)?
What is the 5-year average Current Ratio for Oncolys BioPharma Inc. (4588.T)?
How does the current Current Ratio for Oncolys BioPharma Inc. (4588.T) compare to its historical average?